Send to

Choose Destination
See comment in PubMed Commons below
J Clin Psychiatry. 2009;70 Suppl 1:4-46.

Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.

Author information

Department of Psychiatry, University of Cincinnati College of Medicine, 260 Stetson St., Suite 3224, Cincinnati, OH 45267-0559, USA. NASRALHA@UCMAIL.UC.EDU


In mid-February 2008, a panel of 10 nationally recognized schizophrenia research experts was assembled in a Schizophrenia Summit to focus on controversies that exist in treating patients with schizophrenia. The current literature related to the diagnosis and etiopathology of schizophrenia was evaluated regarding the identification of a prodromal phase, brain changes, cognitive impairments, genetic factors, and use of neuroimaging in patients with schizophrenia. Further, consideration was given to evidence supporting the neuroprotective benefits of atypical antipsychotic medications, the benefits of treating patients during the prodromal period, the use of combination antipsychotic medications, the need to improve cognitive function, and the management of substance abuse. Summit faculty member opinion is compared with field survey results, and recommendations are made for future research.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Physicians Postgraduate Press, Inc.
    Loading ...
    Support Center